Leah F. Moriarty

Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study

Aline Uwimana, Noella Umulisa, Meera Venkatesan et al. · The Lancet Infectious Diseases · 2021 · 473 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020

Leah F. Moriarty, Mateusz M. Pluciński, Barbara J. Marston et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 430 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018

Adama Gansané, Leah F. Moriarty, Didier Ménard et al. · Malaria Journal · 2021 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance

Leah F. Moriarty, Papy Mandoko Nkoli, Joris Losimba Likwela et al. · American Journal of Tropical Medicine and Hygiene · 2021 · 67 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Chris Ebong, Asadu Sserwanga, Jane Frances Namuganga et al. · Malaria Journal · 2021 · 59 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17